Siegina G. Evers
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Cancer therapeutics and mechanisms 2
- Genomics and Chromatin Dynamics 2
- Oncology 6
- Lung Cancer Research Studies 4
- Co-authors
- Sjoerd Rodenhuis (7 shared papers)Johannes L. Bos (2 shared papers)Wolter J. Mooi (4 shared papers)Nico van Zandwijk (1 shared paper)Robbert J.C. Slebos (2 shared papers)S S Wagenaar (2 shared papers)W. J. Mooi (1 shared paper)Peter C. Van Bodegom (1 shared paper)
- Journals
- Diagnostic Molecular Pathology (2 papers)Cancer (1 paper)British Journal of Cancer (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Cancer Letters (1 paper)
- Partner nations
- NetherlandsUnited States
In The Last Decade
Siegina G. Evers
15 papers receiving 1.1k citations
Siegina G. Evers's Hit Papers
Peers
Comparison fields: 5 of 71
- Cancer Research 330
- Oncology 597
- Pulmonary and Respiratory Medicine 543
- Molecular Biology 612
- Pathology and Forensic Medicine 128
Countries citing papers authored by Siegina G. Evers
This map shows the geographic impact of Siegina G. Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siegina G. Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siegina G. Evers more than expected).
Fields of papers citing papers by Siegina G. Evers
This network shows the impact of papers produced by Siegina G. Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siegina G. Evers. The network helps show where Siegina G. Evers may publish in the future.
Co-authors
The 20 scholars most cited alongside Siegina G. Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mutational Activation of the K-rasOncogene Hit paper breakdown → | 1987 | 450 |
| 2 | Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. | 1988 | 386 |
| 3 | 1993 | 161 | |
| 4 | 1976 | 57 | |
| 5 | 1992 | 42 | |
| 6 | 1989 | 37 | |
| 7 | 1981 | 11 | |
| 8 | 1981 | 9 | |
| 9 | 1981 | 9 | |
| 10 | 1974 | 9 | |
| 11 | 1991 | 8 | |
| 12 | 1981 | 8 | |
| 13 | 1988 | 3 | |
| 14 | 1992 | 2 | |
| 15 | 1985 | 1 | |
| 16 | 1987 | 0 |
About Siegina G. Evers
Siegina G. Evers is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Genetics and Epidemiology, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Estrogen and related hormone effects (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Lung Cancer Research Studies (4 papers), Cancer Genomics and Diagnostics (2 papers), Cancer therapeutics and mechanisms (2 papers), Genomics and Chromatin Dynamics (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Cancer Research (330 citations), Oncology (597 citations), Pulmonary and Respiratory Medicine (543 citations), Molecular Biology (612 citations) and Pathology and Forensic Medicine (128 citations). Siegina G. Evers has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Sjoerd Rodenhuis, Johannes L. Bos, Wolter J. Mooi, Nico van Zandwijk, Robbert J.C. Slebos, S S Wagenaar, W. J. Mooi, Peter C. Van Bodegom, Mels Sluyser and William H. Westra. Their work appears in journals such as Diagnostic Molecular Pathology, Cancer, British Journal of Cancer, JNCI Journal of the National Cancer Institute and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.